Holte H - Search Results

1

The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.

Blaker YN, Spetalen S, Brodtkorb M, Lingjaerde OC, Beiske K, Østenstad B, Sander B, Wahlin BE, Melen CM, Myklebust JH, Holte H, Delabie J, Smeland EB. Blaker YN, et al. Among authors: holte h. Br J Haematol. 2016 Oct;175(1):102-14. doi: 10.1111/bjh.14201. Epub 2016 Jun 24. Br J Haematol. 2016. PMID: 27341313 Free article.

2

Differential chromatin structure-dependent binding of 7-aminoactinomycin D in normal and malignant bone marrow hematopoietic cells.

Stokke T, Holte H, Smeland EB, Lie SO, Steen HB. Stokke T, et al. Among authors: holte h. Cancer Res. 1992 Sep 15;52(18):5007-12. Cancer Res. 1992. PMID: 1516056

3

Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation.

Funderud S, Erikstein B, Asheim HC, Nustad K, Stokke T, Blomhoff HK, Holte H, Smeland EB. Funderud S, et al. Among authors: holte h. Eur J Immunol. 1990 Jan;20(1):201-6. doi: 10.1002/eji.1830200129. Eur J Immunol. 1990. PMID: 1689662

4

Cyclic AMP has the ability to influence multiple events during B cell stimulation.

Holte H, Torjesen P, Blomhoff HK, Ruud E, Funderud S, Smeland EB. Holte H, et al. Eur J Immunol. 1988 Sep;18(9):1359-66. doi: 10.1002/eji.1830180909. Eur J Immunol. 1988. PMID: 2458941

5

Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets.

Beiske K, Clark EA, Holte H, Ledbetter JA, Smeland EB, Godal T. Beiske K, et al. Among authors: holte h. Int J Cancer. 1988 Oct 15;42(4):521-8. doi: 10.1002/ijc.2910420409. Int J Cancer. 1988. PMID: 2459071

6

Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens.

Holte H, Blomhoff HK, Beiske K, Funderud S, Torjesen P, Gaudernack G, Stokke T, Smeland EB. Holte H, et al. Eur J Immunol. 1989 Jul;19(7):1221-5. doi: 10.1002/eji.1830190711. Eur J Immunol. 1989. PMID: 2547623

7

Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma.

Holte H, de Lange Davies C, Beiske K, Stokke T, Marton PF, Smeland EB, Høie J, Kvaløy S. Holte H, et al. Int J Cancer. 1989 Dec 15;44(6):975-80. doi: 10.1002/ijc.2910440605. Int J Cancer. 1989. PMID: 2606582

8

Levels of myc protein, as analyzed by flow cytometry, correlate with cell growth potential in malignant B-cell lymphomas.

Holte H, Stokke T, Smeland E, Watt R, Blomhoff HK, Kaalhus O, Ohlsson R. Holte H, et al. Int J Cancer. 1989 Jan 15;43(1):164-70. doi: 10.1002/ijc.2910430130. Int J Cancer. 1989. PMID: 2642893

9

Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads.

Kvalheim G, Jakobsen E, Holte H, Beiske K, Langholm R, Høiby A, Wang MY, Funderund S, Fodstad O, Smeland E, et al. Kvalheim G, et al. Among authors: holte h. Prog Clin Biol Res. 1994;389:133-8. Prog Clin Biol Res. 1994. PMID: 7700895 No abstract available.

10

Expression of CD18 (integrin beta 2 chain) correlates with prognosis in malignant B cell lymphomas.

Erikstein BK, Holte H, Kvaløy S, Andersson KB, Steen HB, Hannisdal E, Smeland EB. Erikstein BK, et al. Among authors: holte h. Br J Haematol. 1993 Mar;83(3):392-8. doi: 10.1111/j.1365-2141.1993.tb04662.x. Br J Haematol. 1993. PMID: 8097923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters